Beximco Pharmaceuticals Ltd GDR (LSE:BXP) - Overview

Stock Report

Beximco Pharmaceuticals Ltd BXP

Last Price
GBX50.90

Day Change
1.40|2.83%

As of 09/12/2016
12:48:26 GMT | GBX
Minimum 15 Minutes Delay.

Last Close49.50p
Day Range48.08 - 50.90
Mkt Cap191.20Mil
52-Wk Range23.00 - 57.00
Yield %1.08
ISINUS0885792061
Volume37,863
P/E11.69
P/S1.72
P/CF10.86

Share Price

Total Returns 08/12/2016

 Chg (%)  
More ...
Beximco Pharmaceuticals Ltd2.06 
FTSE 100 TR GBP1.73
 
Financials
201420152016
More ...
Income Statement
Turnover87.75-114.44
Operating Profit18.93-25.47
Net Profit11.97-16.84
Reported EPS3.10-4.36
Balance Sheet
Current Assets68.85-81.36
Non Current Assets169.82-215.80
Total Assets238.67-297.16
Current Liabilities38.75-28.45
Total Liabilities66.50-77.17
Total Equity172.17-219.99
Cash Flow
Operating Cash Flow22.27-26.00
Net Change in Cash-2.92--0.01
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
201729.155.4725.509.050.36--

Company Profile

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing of generic pharmaceuticals formulation products which includes life saving intravenous fluids and Active Pharmaceutical Ingredients.
 

Sector

Drug Manufacturers - Major

Market Position

700 of 1863 Companies

Index

Outlook

(15/11/2016) no outlook statement

Next Event 31/01/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)0.0013.3915.97
Div Yld (E)0.004.244.18
PEG (E)0.000.220.27
ROCE9.33204.18-30.67
Op Mrgn21.17-17.37-33.06
EPS Grwth0.009.7722.66
Dividends
PreviousLatest
More ...
Record Date31/10/1611/05/16
Ex-Div28/10/1610/05/16
Paidt.b.c.04/07/16
Amnt0.470.89

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanAhmed Rahman
Managing DirectorMr. Hassan Nazmul
Company SecretaryMohammad Asad Ullah
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.